End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
189,000 KRW | +2.89% | +5.76% | -6.20% |
04-24 | Market Share of Celltrion’s Remsima Rises to 74% in Europe | MT |
04-17 | Celltrion, Inc. announces an Equity Buyback for 436,047 shares. | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.20% | 28.31B | |
+22.15% | 42.68B | |
-3.43% | 42.4B | |
+45.32% | 40.04B | |
+7.73% | 24.94B | |
-19.89% | 18.96B | |
+29.39% | 12.3B | |
-2.88% | 11.95B | |
-1.75% | 11.55B | |
+16.95% | 11.32B |
- Stock Market
- Equities
- A068270 Stock
- News Celltrion, Inc.
- Celltrion's Biosimilar Remsima Sales Reach New High in 2021 in the US